Clinical Trial: Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA(R)) in House Dust Mite Allergic Rhinitis- ACARAY Study

U.S., Sept. 30 -- ClinicalTrials.gov registry received information related to the study (NCT07196527) titled 'Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA(R)) in House Dust Mite Allergic Rhinitis- ACARAY Study' on Sept. 10.

Brief Summary: Justification of the relevance of the research:

Patients suffering from allergic rhinitis are looking for several therapeutic options to control their symptoms. Although etiological treatment is based on allergen immunotherapy, and most prescribed symptomatic therapies include antihistamines and/or topical corticoids, patients tend to self-medicate and seek different options, also choosing non-pharmacological approaches, particularly when symptoms are milder; n...